RankingsPricing
  1. US-listed companies
  2. CAPRICOR THERAPEUTICS, INC.
  3. Financials
  4. Total current liabilities

CAPRICOR THERAPEUTICS, INC.CAPR

Market cap
$1.2B
P/E ratio
SummaryFinancials
Period EndTotal current liabilities (Million USD)YoY (%)
Dec 31, 202421-32.76%
Dec 31, 202331+32.57%
Dec 31, 202224+470.63%
Dec 31, 20214+39.11%
Dec 31, 20203+230.88%
Dec 31, 20191-28.46%
Dec 31, 20181-24.87%
Dec 31, 20172-65.87%
Dec 31, 20165-25.02%
Dec 31, 20157+3.64%
Dec 31, 20146+206.86%
Dec 31, 20132+279.15%
Dec 31, 20111

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)